Tandem Diabetes Care | TNDM - Ordinary Share Capital


Tandem Diabetes Care reported $68.29M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Accuray USD 100K 1000 Sep/2024
Align Technology USD 71.75M 736K Dec/2025
AtriCure USD 49.7M 10K Sep/2025
Baxter International USD 514.28M 168.72M Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Cooper Companies USD 195.1M 3.71M Dec/2025
Dexcom USD 384.8M 5.2M Dec/2025
Edwards Lifesciences USD 580.7M 7.2M Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Globus Medical USD 135.06M 449K Dec/2025
ICU Medical USD 24.69M 2K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 70.35M 1000 Dec/2025
Integra LifeSciences USD 77.89M 34K Dec/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
J&J USD 2.41B 584K Sep/2025
Masimo USD 52.1M 1000K Dec/2025
Medtronic USD 1.28B 116K Sep/2025
Merit Medical Systems USD 59.29M 72K Sep/2025
Orthofix International USD 39.83M 315K Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.19M 1000 Dec/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025